ATE465412T1 - Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen - Google Patents

Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen

Info

Publication number
ATE465412T1
ATE465412T1 AT04818645T AT04818645T ATE465412T1 AT E465412 T1 ATE465412 T1 AT E465412T1 AT 04818645 T AT04818645 T AT 04818645T AT 04818645 T AT04818645 T AT 04818645T AT E465412 T1 ATE465412 T1 AT E465412T1
Authority
AT
Austria
Prior art keywords
epilepsy
immunosorb
assessing
blood tests
paroxysmal cerebral
Prior art date
Application number
AT04818645T
Other languages
English (en)
Inventor
Svetlana Dambinova
Galina Izykenova
Original Assignee
Grace Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grace Lab Inc filed Critical Grace Lab Inc
Application granted granted Critical
Publication of ATE465412T1 publication Critical patent/ATE465412T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2857—Seizure disorders; Epilepsy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
AT04818645T 2003-11-06 2004-11-08 Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen ATE465412T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51767103P 2003-11-06 2003-11-06
PCT/US2004/037088 WO2005046442A2 (en) 2003-11-06 2004-11-08 Immunosorbent tests for assessing paroxysmal cerebral discharges

Publications (1)

Publication Number Publication Date
ATE465412T1 true ATE465412T1 (de) 2010-05-15

Family

ID=34590180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04818645T ATE465412T1 (de) 2003-11-06 2004-11-08 Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen

Country Status (10)

Country Link
US (1) US7820398B2 (de)
EP (1) EP1689288B1 (de)
JP (1) JP4838140B2 (de)
CN (1) CN1954211A (de)
AT (1) ATE465412T1 (de)
AU (1) AU2004288717A1 (de)
CA (1) CA2585876A1 (de)
DE (1) DE602004026767D1 (de)
EA (1) EA200600920A1 (de)
WO (1) WO2005046442A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6896872B2 (en) * 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
US8084225B2 (en) * 2005-06-13 2011-12-27 Cis Biotech, Inc. Methods for diagnosing cerebrovascular events based on NR2 peptides
US8536115B2 (en) 2006-08-31 2013-09-17 Centre For Addiction And Mental Health Compositions and methods for modulating AMPA receptor-mediated excitotoxicity
WO2013102264A1 (en) * 2012-01-04 2013-07-11 Centre For Addiction And Mental Health Compositions and methods for modulating ampa receptor-mediated excitotoxicity
US10610861B2 (en) 2012-12-17 2020-04-07 Accellix Ltd. Systems, compositions and methods for detecting a biological condition
US9759722B2 (en) * 2012-12-17 2017-09-12 Leukodx Ltd. Systems and methods for determining a chemical state
CN105051538B (zh) 2012-12-17 2018-06-15 伦珂德克斯有限公司 用于检测生物状况的系统和方法
EP2863231A1 (de) * 2013-10-17 2015-04-22 Institut D'Investigaciones Biomédiques August Pi i Sunyer Diagnostisches Verfahren zum Nachweis einer GABA(A)-verwandten Autoimmunerkrankung und zugehörige Subjektmaterie
US9958521B2 (en) 2015-07-07 2018-05-01 Q Bio, Inc. Field-invariant quantitative magnetic-resonance signatures
US10194829B2 (en) 2015-07-07 2019-02-05 Q Bio, Inc. Fast scanning based on magnetic resonance history
US9665734B2 (en) 2015-09-12 2017-05-30 Q Bio, Inc. Uniform-frequency records with obscured context
US10964412B2 (en) 2015-10-20 2021-03-30 Q Bio, Inc. Population-based medical rules via anonymous sharing
US10222441B2 (en) 2016-04-03 2019-03-05 Q Bio, Inc. Tensor field mapping
US10359486B2 (en) 2016-04-03 2019-07-23 Q Bio, Inc. Rapid determination of a relaxation time
US20180225424A1 (en) * 2017-02-03 2018-08-09 Q Bio, Inc Iterative medical testing of biological samples
US11650195B2 (en) 2017-02-03 2023-05-16 Q Bio, Inc. Iterative medical testing of biological samples
US10936180B2 (en) 2017-03-16 2021-03-02 Q Bio, Inc. User interface for medical information
US11360166B2 (en) 2019-02-15 2022-06-14 Q Bio, Inc Tensor field mapping with magnetostatic constraint
US11354586B2 (en) 2019-02-15 2022-06-07 Q Bio, Inc. Model parameter determination using a predictive model
WO2020241443A1 (ja) 2019-05-24 2020-12-03 富士レビオ株式会社 サイログロブリンの測定方法及び測定試薬
CN114514427A (zh) 2019-09-27 2022-05-17 富士瑞必欧株式会社 乙型肝炎病毒核心相关抗原的免疫测定和用于其的试剂盒
US11131735B2 (en) 2019-09-27 2021-09-28 Q Bio, Inc. Maxwell parallel imaging
US12320880B2 (en) 2019-09-27 2025-06-03 Q Bio, Inc. Maxwell parallel imaging
US11614509B2 (en) 2019-09-27 2023-03-28 Q Bio, Inc. Maxwell parallel imaging
JP7606506B2 (ja) 2020-03-31 2024-12-25 富士レビオ株式会社 血中アミロイドβの免疫測定方法及びそのためのキット
US20250147029A1 (en) 2021-08-06 2025-05-08 Advanced Life Science Institute, Inc. Immunoassay for thyroglobulin and kit therefor
US11614508B1 (en) 2021-10-25 2023-03-28 Q Bio, Inc. Sparse representation of measurements

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879289A (en) * 1988-05-24 1989-11-07 Marion Laboratories, Inc. Method of ameliorating epileptic seizures
DE69034138T2 (de) * 1989-10-27 2005-05-12 The Salk Institute For Biological Studies, La Jolla Rezeptorverbindungen von glutamin und herstellung
EP0558747B1 (de) 1991-06-26 1998-01-07 Obschestvo S Ogranichennoi Otvetstvennostju " Dies" Immunadsorbens zur diagnose von epilepsie und der risikogruppe
JP2782695B2 (ja) 1992-09-11 1998-08-06 ダムビノヴァ，スヴェトラーナ・アレクサンドロフナ 神経症および精神病の診断用免疫吸着剤およびその実際的用途
RU2112243C1 (ru) 1995-11-29 1998-05-27 Светлана Александровна Дамбинова Набор "па-тест" для диагностики неврологических заболеваний
US6896872B2 (en) * 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
US20050233390A1 (en) * 2003-04-09 2005-10-20 Allen John W Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery

Also Published As

Publication number Publication date
EP1689288A4 (de) 2007-09-26
EP1689288B1 (de) 2010-04-21
AU2004288717A2 (en) 2005-05-26
US7820398B2 (en) 2010-10-26
EA200600920A1 (ru) 2007-04-27
AU2004288717A1 (en) 2005-05-26
WO2005046442A3 (en) 2006-12-07
EP1689288A2 (de) 2006-08-16
CN1954211A (zh) 2007-04-25
DE602004026767D1 (de) 2010-06-02
WO2005046442A2 (en) 2005-05-26
JP2007517188A (ja) 2007-06-28
CA2585876A1 (en) 2005-05-26
JP4838140B2 (ja) 2011-12-14
US20050181466A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
ATE465412T1 (de) Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen
Galvez-Sánchez et al. Depression and trait-anxiety mediate the influence of clinical pain on health-related quality of life in fibromyalgia
Gallagher et al. Ageing: the cholinergic hypothesis of cognitive decline
Sammler et al. Prosody meets syntax: the role of the corpus callosum
Chen et al. Treadmill exercise suppressed stress-induced dendritic spine elimination in mouse barrel cortex and improved working memory via BDNF/TrkB pathway
Gillivan-Murphy et al. Voice tremor in Parkinson's disease: an acoustic study
Wang et al. 40-Hz optogenetic stimulation rescues functional synaptic plasticity after stroke
Prestes et al. Temporal processing and long-latency auditory evoked potential in stutterers
Christison-Lagay et al. Behavioral correlates of auditory streaming in rhesus macaques
Ferreira‐Junior et al. Exercise training increases GAD65 expression, restores the depressed GABAA receptor function within the PVN and reduces sympathetic modulation in hypertension
Ris et al. Sexual dimorphisms in the effect of low‐level p25 expression on synaptic plasticity and memory
da Silva et al. Localized APP expression results in progressive network dysfunction by disorganizing spike timing
Tacik et al. Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1
Bonin-Guillaume et al. An additive factor analysis of the effect of depression on the reaction time of old patients
GB0403490D0 (en) Screening methods
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
Gupta et al. Effect of Antiepileptic drugs on Psychomotor Functions and Memory in Epilepsy Patients.
Jarkiewicz et al. Can new paradigms bring new perspectives for mismatch negativity studies in schizophrenia?
Safi et al. Recruitment of the left precentral gyrus in reading epilepsy: a multimodal neuroimaging study
De Las Heras et al. Lesion location changes the association between brain excitability and motor skill acquisition post-stroke
Colzato et al. Retraction note to: the effect of gamma-enhancing binaural beats on the control of feature bindings
Yamamoto et al. Characteristic features of electroencephalogram in a pediatric patient with grin1 encephalopathy
Reinhart et al. Assessing neglect dyslexia with compound words.
Šulcová et al. Evaluation of GABAAR-mediated inhibition in the human brain using TMS-evoked potentials
Hamid et al. Stigma of epilepsy among patients and their relatives attending charity clinic, Omdurman—Sudan

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties